Literature DB >> 10365358

An evaluation of the autopsy following death in a level IV neonatal intensive care unit.

P Barr1, R Hunt.   

Abstract

OBJECTIVE: To ascertain the determinants of neonatal autopsy, define clinical errors in the causes of death, and elucidate the possible audit and genetic value of the autopsy following death in a Level IV neonatal intensive care unit (NICU).
METHODS: A review and correlation of clinical and autopsy information in a case series of infants who died during the period 1991-97.
RESULTS: Two hundred and twenty-nine of 4057 infants admitted to the NICU died and 91 (39.7%) underwent an autopsy. The underlying cause of death was significantly different in infants who had an autopsy compared with infants who did not (P = 0.02). The autopsy rate was higher for deaths from miscellaneous causes (52.9%), lethal malformation (46.8%) and infection (45.4%) than deaths from prematurity (25.9%) and asphyxia (19%). Clinical errors in the causes of death were found in 22% of the infants, and in 4.4% a change in management may have been curative or prolonged life. The autopsy had audit value in 26% of infants and genetic value for a single gene (Mendelian) disorder in 4.4%.
CONCLUSIONS: Although the autopsy following death in a Level IV NICU yields potentially useful information in more than one-third of cases, this does not seem sufficient to ensure a high neonatal autopsy rate.

Entities:  

Mesh:

Year:  1999        PMID: 10365358     DOI: 10.1046/j.1440-1754.1999.t01-1-00338.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  Value of postmortem studies in deceased neonatal and pediatric intensive care unit patients.

Authors:  Raphael Widmann; Rosmarie Caduff; Luca Giudici; Qing Zhong; Alexander Vogetseder; Romaine Arlettaz; Bernhard Frey; Holger Moch; Peter K Bode
Journal:  Virchows Arch       Date:  2016-12-14       Impact factor: 4.064

2.  Autopsy in a Neonatal Intensive Care Unit: pathological and clinical agreement.

Authors:  Camila Penso; Andréa L Corso; Cláudia R Hentges; Rita C Silveira; Raquel C Rivero; Bruna S Rojas; Tatiana S Tellechea; Renato S Procianoy
Journal:  J Pediatr (Rio J)       Date:  2022-02-19       Impact factor: 2.990

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.